Journal profile · Cell Biology

Cell Proliferation

ISSN 0960-7722 · eISSN 1365-2184 · Wiley-Blackwell Publishing Ltd · ENGLAND · Quarterly · Founded 1991

Cell Proliferation: CAS Zone 1 · Biology (2025 upgraded edition, Top journal); impact factor 7.38; fully open access; APC about USD 3,680; median 101 days to acceptance (93 articles, last 24 months); community-reported acceptance: about 50%; 209 articles in 2025; indexed in SCIE and Scopus.

Impact factor7.38Latest value listed by LetPub
CAS zoneZone 1 · Biology2025 upgraded edition, major category · Top journal · 2026 Xinrui edition Zone 1 · Biology
Review time101 daysMedian, submission to acceptance · 93 articles, last 24 months · Crossref
APCUSD 3,680Fully open access
Acceptanceabout 50%Community average
Articles per year2092025 · OpenAlex count

Scope

Aims, scope and focus

Cell Proliferation is published by Wiley-Blackwell Publishing Ltd and is in Zone 1 of Biology in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Mesenchymal stem cell research, Cancer Cells and Metastasis and Pluripotent Stem Cells Research, together about 25.9% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

Cell Proliferation is an open access journal devoted to studies into all aspects of cell proliferation and differentiation in normal and abnormal states; control systems and mechanisms operating at inter- and intracellular, molecular and genetic levels; modification by and interactions with chemical and physical agents; mathematical modelling; and the development of new techniques. In addition to original research papers Cell Proliferation publishes invited review articles, book reviews and letters commenting on previously published papers and/or topics of general interest.

From the journal's Aims & Scope

Research area (LetPub): Cell Biology

Editor-in-chief Xiu-Wu BianPublisher website

Editorial board by country: 24 in mainland China (about 44%); most named Mainland China 24, United States 8, United Kingdom 4, Germany 4, Japan 2 (54 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Mesenchymal stem cell researchMedicine9.8%
  2. Cancer Cells and MetastasisMedicine8.2%
  3. Pluripotent Stem Cells ResearchBiochemistry, Genetics and Molecular Biology8%
  4. MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology4.7%
  5. Reproductive Biology and FertilityMedicine4.7%
  6. Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology4.5%
  7. Cancer-related Molecular PathwaysMedicine4.4%
  8. Microtubule and mitosis dynamicsBiochemistry, Genetics and Molecular Biology4.4%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 1
LevelCategoryZone
MajorBiologyZone 1
MinorCell BiologyZone 1

Top journal: yesReview journal: no

CAS Xinrui Journal Ranking (March 2026)Biology Zone 1
LevelCategoryZone
MajorBiologyZone 1
MinorCell BiologyZone 2

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Biology Zone 1
LevelCategoryZone
MajorBiologyZone 1
MinorCell BiologyZone 2

Top journal: yesReview journal: no

Database indexing

SCIEScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

MEDLINEPubMedEmbaseCurrent ContentsPublisher website

Other: EBSCO

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
7.38LetPub ·
Impact factor (publisher)
7.6Publisher website ·
Impact factor (publisher) 2025
7.6Publisher website ·
CiteScore 2026-06
12.3LetPub ·
CiteScore (publisher)
12.3Publisher website ·
CiteScore (publisher) 2025
12.3Publisher website ·
SJR 2026-06
1.99LetPub ·
SNIP 2026-06
1.36LetPub ·
h-index
66LetPub ·
h-index
140OpenAlex ·
i10-index
2,765OpenAlex ·
2-year mean citedness
6.02OpenAlex ·
Self-citation rate
2.6%LetPub ·
Share of gold OA articles
100%LetPub ·

Volume

Articles per year
142LetPub ·
Articles per year (publisher)
2Publisher website ·
Articles per year (publisher) 2025
164Publisher website ·
Downloads per year (publisher) 2025
1,029,456Publisher website ·

Articles by year OpenAlex count · 5,023 in total · the current year is incomplete

YearArticlesOpen accessCitations
202613313348
2025209209930
20242202202,403
20232132133,863
20222252254,884
20212112118,100

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with Crossref · to

101 daysMedian, submission to acceptance · P25–P75 72 days – 145 days

Acceptance to online
median 16 days (93 articles)
Submission to online
median 123 days
Sample
93 articles with submission and acceptance dates (369 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
about 1 monthLetPub ·
Average acceptance (community reports)
50%LetPub ·
Acceptance rate (publisher)
9%Publisher website ·
Acceptance rate (publisher) 2025
9%Publisher website ·
Submission to first decision
5 daysPublisher website ·
Submission to first decision 2025
5 daysPublisher website ·
Submission to acceptance 2025
91 daysPublisher website ·
Acceptance to publication 2025
15 daysPublisher website ·
Submission to publication (journal-reported)
about 7 weeksDOAJ ·
Peer review
Single anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJEUR 3,100 / GBP 2,730 / USD 3,680YesCC BY
OpenAlexUSD 3,680 / EUR 3,100 / GBP 2,730——

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

What to prepare7 items from the author guidelines
Abstract
≤ 300 words
Keywords
≤ 7
Manuscript length
≤ 3,000 words
Reference style
Author–date
First submission
Free format: the journal's layout is not required
Highlights
Optional
Graphical abstract
Required
Publisher website · model-extracted, each line checked against the text
Article types accepted15
  1. abstracts2.8 Abstracts Description: Published abstracts from conferences. Requirements: Conflict of Interest.Length not stated
  2. brief report2.1 Original Article Description: New research findings or conceptual analyses. Requirements: Unstructured, Author Contribution, Data Availability, Conflict of …Length not stated
  3. case report2.1 Original Article Description: New research findings or conceptual analyses. Requirements: Unstructured, Author Contribution, Data Availability, Conflict of …Length not stated
  4. commentary2.1 Original Article Description: New research findings or conceptual analyses. Requirements: Unstructured, Author Contribution, Data Availability, Conflict of …Length not stated
  5. editorial2.1 Original Article Description: New research findings or conceptual analyses. Requirements: Unstructured, Author Contribution, Data Availability, Conflict of …Length not stated
  6. letter2.1 Original Article Description: New research findings or conceptual analyses. Requirements: Unstructured, Author Contribution, Data Availability, Conflict of …Length not stated
  7. literature review2.1 Original Article Description: New research findings or conceptual analyses. Requirements: Unstructured, Author Contribution, Data Availability, Conflict of …Length not stated
  8. meeting report2.7 Meeting Report Description: Summary of meeting developments. Requirements: Conflict of Interest.Length not stated
  9. meta-analysis2.1 Original Article Description: New research findings or conceptual analyses. Requirements: Unstructured, Author Contribution, Data Availability, Conflict of …Length not stated
  10. opinion2.1 Original Article Description: New research findings or conceptual analyses. Requirements: Unstructured, Author Contribution, Data Availability, Conflict of …Length not stated
  11. original article2.1 Original Article Description: New research findings or conceptual analyses. Requirements: Unstructured, Author Contribution, Data Availability, Conflict of …Length not stated
  12. perspective2.1 Original Article Description: New research findings or conceptual analyses. Requirements: Unstructured, Author Contribution, Data Availability, Conflict of …Length not stated
  13. practice and policy2.5 Practice and Policy Description: Public statement of what a representative group of experts agree to be evidence-based and state-of-the-art knowledge on an …Length not stated
  14. review2.1 Original Article Description: New research findings or conceptual analyses. Requirements: Unstructured, Author Contribution, Data Availability, Conflict of …Length not stated
  15. systematic review2.1 Original Article Description: New research findings or conceptual analyses. Requirements: Unstructured, Author Contribution, Data Availability, Conflict of …Length not stated
Publisher website
Policy excerpts from the journal's websiteAI use, Authorship, Data availability, License & copyright, Open access, Peer review, Preprints
AI use 1.17 AI Policy

AI policy. Model summary

Artificial Intelligence Generated Content (AIGC) tools—such as ChatGPT and others based on large language models (LLMs)—cannot be considered capable of initiating an original piece of research without direction by human authors. They also cannot be accountable for a published work or for research design, which is a generally held requirement of authorship (as discussed in the previous section), no…

Source ↗Publisher website ·
Authorship 1.7 Authorship, Pronouns, and ORCID

AuthorshipAll listed authors should have contributed to the manuscript substantially and have agreed to the final submitted version. Review editorial standards and scroll down for a description of authorship criteria. Author PronounsAuthors may now include their personal pronouns in the author bylines of their published articles and on Wiley Online Library. Authors will never be required to includ…

Source ↗Publisher website ·
Data availability

Data sharing policy. Model summary

This journal expects and peer reviews data sharing.

Source ↗Publisher website ·
License & copyright 1.8 Reproduction of Copyright Material

If excerpts from copyrighted works owned by third parties are included, all sources must be credited within the manuscript. At minimum, the title and author should be provided. The corresponding author is responsible for obtaining written permission to reproduce the material "in print and other media" from the publisher of the original source, and for supplying Wiley with that permission upon requ…

Source ↗Publisher website ·
Open access 1.3 Open Access

This journal is a Gold Open Access journal. Submissions will be subject to an APC if accepted and published in the journal. You can read more about APCs and whether you may be eligible for waivers or discounts, through your institution, funder, or a country waiver. For more information on this journal’s APCs and licensing policy, please visit the journal’s Open Access page.

Source ↗Publisher website ·
Peer review 1. Submission and Peer Review Process

Single-anonymized peer review policy. Model summary

Thank you for your interest in Cell Proliferation. Please note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting on symposium. New submissions should be made via the Research Exchange submission portal https://authors.wiley.com/journal/CPR. You may check the status of your sub…

Source ↗Publisher website ·
Preprints 1.4 Preprint Policy

Preprint policy. Model summary

Please find the Wiley preprint policy here. This journal accepts articles previously published on preprint servers. Cell Proliferation will consider for review articles previously available as preprints. You are requested to update any pre-publication versions with a link to the final published article. You may also post the final published version of the article immediately after publication.

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Wiley-Blackwell Publishing Ltd
Country or region
ENGLAND
Language
English
Frequency
Quarterly
Founded
1991
ISSN
0960-7722
Electronic ISSN
1365-2184
Society / sponsor
Beijing Institute for Stem Cell and Regenerative Medicine
Latest issue on the website
Volume 59, Issue 9 (September 2026)
Official links

FAQ

Frequently asked questions about Cell Proliferation

What CAS zone is Cell Proliferation in?

In the 2025 upgraded edition of the CAS Journal Ranking, Cell Proliferation is in Zone 1 of Biology, and in Zone 1 of the minor category Cell Biology; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Cell Proliferation?

The latest impact factor listed by LetPub is 7.38; CiteScore 12.3, h-index 140.

How long does peer review take at Cell Proliferation?

Based on the dates recorded on 93 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 101 days (interquartile range 72–145 days); authors report an average review time of about 1 month; the community-reported acceptance is “about 50%”; the journal's website gives an acceptance rate of 9% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

What are the manuscript requirements of Cell Proliferation?

According to the journal's author guidelines: Abstract: ≤ 300 words; Keywords: ≤ 7; Manuscript length: ≤ 3,000 words; Reference style: Author–date; First submission: Free format: the journal's layout is not required; Highlights: Optional; Graphical abstract: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.

Where are the editorial board members of Cell Proliferation based?

Of the 54 board members whose country the journal's board page names, 24 (about 44%) are in mainland China; the countries named most often are Mainland China (24), United States (8) and United Kingdom (4). Counted from the institutions listed on the board page; for reference only.

Which databases index Cell Proliferation?

According to LetPub and DOAJ records, Cell Proliferation is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE, PubMed, Embase and Current Contents; that list has not been checked against each database.

Is Cell Proliferation open access, and what is the APC?

Cell Proliferation is a fully open-access journal. APC about USD 3,680.

Sources and updates

The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .